FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,230,868 | +34.5% | 727,673 | 0.0% | 0.09% | +52.6% |
| Q2 2023 | $2,401,321 | +15.8% | 727,673 | 0.0% | 0.06% | +16.3% |
| Q1 2023 | $2,073,868 | -25.9% | 727,673 | +89.2% | 0.05% | -26.9% |
| Q4 2022 | $2,799,815 | -10.0% | 384,590 | 0.0% | 0.07% | -16.2% |
| Q3 2022 | $3,111,000 | +65.1% | 384,590 | 0.0% | 0.08% | +45.5% |
| Q2 2022 | $1,884,000 | -81.7% | 384,590 | -11.5% | 0.06% | -78.8% |
| Q1 2022 | $10,278,000 | +27.1% | 434,590 | -4.9% | 0.26% | +38.5% |
| Q4 2021 | $8,084,000 | -37.1% | 456,990 | +0.4% | 0.19% | -30.7% |
| Q3 2021 | $12,844,000 | – | 455,290 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |